CNS and Neurodegenerative Targets

The identification of therapeutic targets based on novel mechanistic approaches is urgently needed for CNS and neurodegenerative diseases, particularly for conditions such as Alzheimer’s which represent extensive unmet medical need and blockbuster potential for the right therapy.

Driven by an improving understanding of CNS disease biology and the emergence of new mechanisms and targets, Cambridge Healthtech Institute’s CNS and Neurodegenerative Targets conference profiles the latest tools, targets and platforms driving today’s CNS drug discovery strategies, with critical updates and findings in key areas such as new targets for misfolded proteins, tau, GCPRs, kinase inhibitors, genetics, gene therapy, and neuroinflammation.

Who should attend: CSOs, Vice Presidents, Directors, Managers, Researchers, and Scientists from pharma, biotechs, academia, government and healthcare organizations working in fields such as CNS drug discovery, R&D, translational & biomedical informatics, and computational biology


Coverage will include, but is not limited to:                                        

  • Latest undestanding and biology behind CNS disease - causes, proven and unproven theories
  • New ways of targeting misfolded proteins
  • Tools to discover CNS new targets
  • Impact of genetics and big data in CNS drug discovery
  • New targets: Tau, GCPRs, BACE, Kinase Inhibitors, PERK inhibitors, peptides
  • Antibody-based therapies – CD20, CD52, CTLA4, PD-L1
  • Inflammatory targets in CNS disease – role of the immune system
  • Neuroinflammation
  • Targets for CNS rare disease
  • New roles for old targets
  • Autophagy
  • Vascular Targets
  • Neuroprotective targets


If you would like to submit a proposal to give a presentation at this meeting, please click here.


The deadline for priority consideration is March 21, 2018.


All proposals are subject to review by session chairmen and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.


For more details on the conference, please contact:
Daniel Barry

Senior Conference Director

Cambridge Healthtech Institute

Phone: (+1) 781-247-6266


For partnering and sponsorship information, please contact:
Rod Eymael

Manager, Business Development

Cambridge Healthtech Institute

Phone: (+1) 781-247-6286